Zoetis (ZTS) EBT Margin (2012 - 2026)

Zoetis' (ZTS) quarterly EBT Margin came in at 33.51% in Q1 2026, down 166.0% year-on-year from 50.77% in Q1 2025, and up 5.11% on a QoQ basis from 31.88% in Q4 2025.

Zoetis (ZTS) EBT Margin (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of EBT Margin data on file, last reported at 33.51% in Q1 2026.

  • On a quarterly basis, EBT Margin fell 166.0% year-over-year to 33.51% in Q1 2026; TTM through Mar 2026 was 34.79%, a 69.0% increase from a year earlier, with the FY2025 full-year figure at 35.49%, up 164.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 33.51%, up from 31.88% in the prior quarter.
  • Over the last five years, EBT Margin for ZTS reached as high as 40.0% in Q2 2023 and fell as low as 29.02% in Q4 2022.
  • Historically, EBT Margin has averaged 34.04% across 5 years, with a median of 33.51% in 2026.
  • Across the five-year window, EBT Margin soared 735 bps in 2023 and sank 696 bps in 2024, its largest moves.
  • Year by year, EBT Margin stood at 29.02% in 2022, then advanced by 1 bps to 29.37% in 2023, then grew by 8 bps to 31.59% in 2024, then gained by 1 bps to 31.88% in 2025, then gained by 5 bps to 33.51% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 33.51% in Q1 2026, 31.88% in Q4 2025, and 36.96% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 10.97%
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 33.51%
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -41.57%
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 40.73%
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn -7.05%
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 30.30%
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 6.35%
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn -3.95%

Historic Data

Download Data
DateValue
Mar 31, 2026 33.51%
Dec 31, 2025 31.88%
Sep 30, 2025 36.96%
Jun 30, 2025 36.67%
Mar 31, 2025 35.17%
Dec 31, 2024 31.59%
Sep 30, 2024 36.60%
Jun 30, 2024 33.04%
Mar 31, 2024 34.11%
Dec 31, 2023 29.37%
Sep 30, 2023 33.33%
Jun 30, 2023 40.00%
Mar 31, 2023 34.85%
Dec 31, 2022 29.02%
Sep 30, 2022 33.32%
Jun 30, 2022 32.65%
Mar 31, 2022 36.61%
Dec 31, 2021 25.72%
Sep 30, 2021 33.12%
Jun 30, 2021 32.65%